{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:24:18Z","timestamp":1790162658200,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002342","name":"Suomalainen Tiedeakatemia","doi-asserted-by":"publisher","award":["9X051"],"award-info":[{"award-number":["9X051"]}],"id":[{"id":"10.13039\/501100002342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002342","name":"Suomalainen Tiedeakatemia","doi-asserted-by":"publisher","award":["AA070"],"award-info":[{"award-number":["AA070"]}],"id":[{"id":"10.13039\/501100002342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s40257-020-00584-2","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T03:41:15Z","timestamp":1610422875000},"page":"329-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Dermatitis Herpetiformis: An Update on Diagnosis and Management"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6271-5189","authenticated-orcid":false,"given":"Timo","family":"Reunala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6759-8399","authenticated-orcid":false,"given":"Kaisa","family":"Hervonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7459-4938","authenticated-orcid":false,"given":"Teea","family":"Salmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"584_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/jama.1983.03340020028029","volume":"250","author":"LA Duhring","year":"1983","unstructured":"Duhring LA. Dermatitis herpetiformis. Landmark article, Aug 30, 1884. JAMA. 1983;250:212\u20136. https:\/\/doi.org\/10.1001\/jama.1983.03340020028029.","journal-title":"JAMA"},{"key":"584_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000116768","volume":"26","author":"MS Losowsky","year":"2008","unstructured":"Losowsky MS. A history of coeliac disease. Dig Dis. 2008;26:112\u201320. https:\/\/doi.org\/10.1159\/000116768.","journal-title":"Dig Dis."},{"key":"584_CR3","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/S0140-6736(66)91692-8","volume":"2","author":"J Marks","year":"1966","unstructured":"Marks J, Shuster S, Watson AJ. Small-bowel changes in dermatitis herpetiformis. Lancet. 1966;2:1280\u20132. https:\/\/doi.org\/10.1016\/S0140-6736(66)91692-8.","journal-title":"Lancet"},{"key":"584_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/s0140-6736(67)91942-3","volume":"2","author":"L Fry","year":"1967","unstructured":"Fry L, Keir P, McMinn RM, Cowan JD, Hoffbrand AV. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet. 1967;2:729\u201333. https:\/\/doi.org\/10.1016\/s0140-6736(67)91942-3.","journal-title":"Lancet"},{"key":"584_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/gut.33.2.206","volume":"33","author":"E Savilahti","year":"1992","unstructured":"Savilahti E, Reunala T, M\u00e4ki M. Increase of lymphocytes bearing the gamma\/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis. Gut. 1992;33:206\u201311. https:\/\/doi.org\/10.1136\/gut.33.2.206.","journal-title":"Gut"},{"key":"584_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2133.1969.tb16024.x","volume":"81","author":"JB van der Meer","year":"1969","unstructured":"van der Meer JB. Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis. An immunofluorescent study. Br J Dermatol. 1969;81:493\u2013503. https:\/\/doi.org\/10.1111\/j.1365-2133.1969.tb16024.x.","journal-title":"Br J Dermatol."},{"key":"584_CR7","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1172\/JCI107123","volume":"51","author":"SI Katz","year":"1972","unstructured":"Katz SI, Falchuk ZM, Dahl MV, Rogentine GN, Strober W. HL-A8: A genetic link between dermatitis herpetiformis and gluten-sensitive enteropathy. J Clin Invest. 1972;51:2977\u201380. https:\/\/doi.org\/10.1172\/JCI107123.","journal-title":"J Clin Invest."},{"key":"584_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0140-6736(73)91539-0","volume":"1","author":"L Fry","year":"1973","unstructured":"Fry L, Seah PP, Riches DJ, Hoffbrand AV. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet. 1973;1:288\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(73)91539-0.","journal-title":"Lancet"},{"key":"584_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2133.1977.tb14122.x","volume":"97","author":"T Reunala","year":"1977","unstructured":"Reunala T, Blomqvist K, Tarpila S, Halme H, Kangas K. Gluten-free diet in dermatitis herpetiformis. I. Clinical response of skin lesions in 81 patients. Br J Dermatol. 1977;97:473\u201380. https:\/\/doi.org\/10.1111\/j.1365-2133.1977.tb14122.x.","journal-title":"Br J Dermatol."},{"key":"584_CR10","first-page":"254","volume":"8","author":"T Reunala","year":"1976","unstructured":"Reunala T, Salo OP, Tiilikainen A, Selroos O, Kuitunen P. Family studies in dermatitis herpetiformis. Ann Clin Res. 1976;8:254\u201361.","journal-title":"Ann Clin Res."},{"key":"584_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1399-0039.1997.tb02834.x","volume":"50","author":"A Balas","year":"1997","unstructured":"Balas A, Vicario JL, Zambrano A, Acuna D, Garc\u0131a-Novo D. Absolute linkage of celiac disease and dermatitis herpetiformis to HLA-DQ. Tissue Antigens. 1997;50:52\u20136. https:\/\/doi.org\/10.1111\/j.1399-0039.1997.tb02834.x.","journal-title":"Tissue Antigens"},{"key":"584_CR12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1046\/j.1523-1747.2000.00172.x","volume":"115","author":"K Hervonen","year":"2000","unstructured":"Hervonen K, Karell A, Holopainen P, Collin P, Partanen J, Reunala T. Concordance of dermatitis herpetiformis and celiac disease in monozygous twins. J Invest Dermatol. 2000;115:990\u20133. https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00172.x.","journal-title":"J Invest Dermatol."},{"key":"584_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrgastro.2015.131","volume":"12","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015;12:561\u201371. https:\/\/doi.org\/10.1038\/nrgastro.2015.131.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"584_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1572-0241.2001.03462.x","volume":"96","author":"PHR Green","year":"2001","unstructured":"Green PHR, Stavropoulos SN, Panagi SG, Goldstein SL, Mcmahon DJ, Absan H, Neugut AI. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96:126\u201331. https:\/\/doi.org\/10.1111\/j.1572-0241.2001.03462.x.","journal-title":"Am J Gastroenterol."},{"key":"584_CR15","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.cgh.2016.11.018","volume":"15","author":"P Dominguez Castro","year":"2017","unstructured":"Dominguez Castro P, Harkin G, Hussey M, Christopher B, Kiat C, Chin JL, Trimble V, McNamara D, MacMathuna P, Egan B, Ryan B, Kevans D, Farrell R, Byrnes V, Mahmud V, McManus R. Changes in presentation of celiac disease in Ireland from the 1960s to 2015. Clin Gastroenterol Hepatol. 2017;15:864\u201371. https:\/\/doi.org\/10.1016\/j.cgh.2016.11.018.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"584_CR16","first-page":"562","volume":"106","author":"LM Kotze","year":"2014","unstructured":"Kotze LM, Vecchia LA, Nisihara R, Kotze LR. Dermatitis herpetiformis in Brazilan male celiac disease patients: a case series. Rev Esp Enferm Dig. 2014;106:562\u20134.","journal-title":"Rev Esp Enferm Dig."},{"key":"584_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1468-3083.2011.04204.x","volume":"26","author":"F Zhang","year":"2012","unstructured":"Zhang F, Yang B, Lin Y, Chen S, Zhou G, Wang G, et al. Dermatitis herpetiformis in China: a report of 22 cases. J Eur Acad Dermatol Venereol. 2012;26:903\u20137. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04204.x.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"584_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/ijd.14029","volume":"57","author":"S Handa","year":"2018","unstructured":"Handa S, Dabas G, De D, Mahajan R, Chatterjee D, Saika UN, Radotra BD. A retrospective study of dermatitis herpetiformis from an immunobullous disease clinic in north India. Int J Dermatol. 2018;57:959\u201364. https:\/\/doi.org\/10.1111\/ijd.14029.","journal-title":"Int J Dermatol."},{"key":"584_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2133.2011.10385.x","volume":"165","author":"TT Salmi","year":"2011","unstructured":"Salmi TT, Hervonen K, Kautiainen H, Collin P, Reunala T. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol. 2011;165:354\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10385.x.","journal-title":"Br J Dermatol."},{"key":"584_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ajg.2014.55","volume":"109","author":"J West","year":"2014","unstructured":"West J, Fleming KM, Tata LJ, Card TR, Crooks CJ. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109:757\u201368. https:\/\/doi.org\/10.1038\/ajg.2014.55.","journal-title":"Am J Gastroenterol."},{"key":"584_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","volume":"391","author":"B Lebwohl","year":"2018","unstructured":"Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391:70\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(17)31796-8.","journal-title":"Lancet"},{"key":"584_CR22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797\u2013801. https:\/\/doi.org\/10.1038\/nm0797-797.","journal-title":"Nat Med."},{"key":"584_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20011299","volume":"195","author":"M S\u00e1rdy","year":"2002","unstructured":"S\u00e1rdy M, K\u00e1rp\u00e1ti S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002;195:747\u201357. https:\/\/doi.org\/10.1084\/jem.20011299.","journal-title":"J Exp Med."},{"key":"584_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/nu12020467","volume":"2020","author":"H Sankari","year":"2020","unstructured":"Sankari H, Hietikko M, Kurppa K, Kaukinen K, Mansikka E, Huhtala H, Laurila K, Reunala T, Hervonen K, Salmi T, Lindfors K. Intestinal transglutaminase 3- and transglutaminase 2-specific plasma cell responses in dermatitis herpetiformis patients undergoing a gluten challenge. Nutrients. 2020;2020:12. https:\/\/doi.org\/10.3390\/nu12020467.","journal-title":"Nutrients."},{"key":"584_CR25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/bjd.13387","volume":"172","author":"T Reunala","year":"2015","unstructured":"Reunala T, Salmi TT, Hervonen K, Laurila K, Kautiainen H, Collin P, Kaukinen K. IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis: a significant but not complete response to a gluten-free diet treatment. Br J Dermatol. 2015;172:1139\u201341. https:\/\/doi.org\/10.1111\/bjd.13387.","journal-title":"Br J Dermatol."},{"key":"584_CR26","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jid.2016.03.039","volume":"136","author":"A G\u00f6r\u00f6g","year":"2016","unstructured":"G\u00f6r\u00f6g A, N\u00e9meth K, Kolev K, Zone JJ, Mayer B, Sill\u00f3 P, Bogn\u00e1r P, K\u00e1rp\u00e1ti S. Circulating transglutaminase 3-Immunoglobulin A immune complexes in dermatitis ferpetiformis. J Invest Dermatol. 2016;136:1729\u201331. https:\/\/doi.org\/10.1016\/j.jid.2016.03.039.","journal-title":"J Invest Dermatol."},{"key":"584_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/jid.2014.368","volume":"135","author":"TB Taylor","year":"2015","unstructured":"Taylor TB, Schmidt LA, Meyer LJ, Zone JJ. Transglutaminase 3 present in the IgA aggregates in dermatitis herpetiformis skin is enzymatically active and binds soluble fibrinogen. J Invest Dermatol. 2015;135:623\u20135. https:\/\/doi.org\/10.1038\/jid.2014.368.","journal-title":"J Invest Dermatol."},{"key":"584_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jaad.2010.09.776","volume":"64","author":"D Bolotin","year":"2011","unstructured":"Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis: part II. Diagnosis, management, and prognosis. J Am Acad Dermatol. 2011;64:1027\u201333. https:\/\/doi.org\/10.1016\/j.jaad.2010.09.776.","journal-title":"J Am Acad Dermatol."},{"key":"584_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00128071-200304010-00002","volume":"4","author":"P Collin","year":"2003","unstructured":"Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am J Clin Dermatol. 2003;4:13\u201320. https:\/\/doi.org\/10.2165\/00128071-200304010-00002.","journal-title":"Am J Clin Dermatol."},{"key":"584_CR30","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/nu12041060","volume":"12","author":"A Alakoski","year":"2020","unstructured":"Alakoski A, Hervonen K, Mansikka E, Reunala T, Kaukinen K, Kivel\u00e4 L, Laurikka P, Huhtala H, Kurppa K, Salmi T. The long-term safety and quality of life effects of oats in dermatitis herpetiformis. Nutrients. 2020;12:1060. https:\/\/doi.org\/10.3390\/nu12041060.","journal-title":"Nutrients."},{"key":"584_CR31","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.dld.2016.01.006","volume":"48","author":"M Spijkerman","year":"2016","unstructured":"Spijkerman M, Tan IJ, Kolkman JJ, Withoff S, Wijmenga C, Wisschedijk MC, Weersma RK. A large variety of clinical features and concomitant disorders in coeliac disease-a cohort study in the Netherlands. Dig Liver Dis. 2016;48:499\u2013505. https:\/\/doi.org\/10.1016\/j.dld.2016.01.006.","journal-title":"Dig Liver Dis."},{"key":"584_CR32","doi-asserted-by":"publisher","first-page":"5965492","DOI":"10.1155\/2017\/5965492","volume":"2017","author":"L Kulczycka-Siennicka","year":"2017","unstructured":"Kulczycka-Siennicka L, Cynkier A, Waszczykowska E, Wo\u017aniacka A, \u017bebrowska A. The Role of Intereukin-31 in pathogenesis of itch and its intensity in a course of bullous pemphigoid and dermatitis herpetiformis. Biomed Res Int. 2017;2017:5965492. https:\/\/doi.org\/10.1155\/2017\/5965492.","journal-title":"Biomed Res Int."},{"key":"584_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-2133.1985.tb02318.x","volume":"112","author":"CE Griffiths","year":"1985","unstructured":"Griffiths CE, Leonard JN, Fry L. Dermatitis herpetiformis exacerbated by indomethacin. Br J Dermatol. 1985;112:443\u20135. https:\/\/doi.org\/10.1111\/j.1365-2133.1985.tb02318.x.","journal-title":"Br J Dermatol."},{"key":"584_CR34","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jdcr.2019.06.011","volume":"5","author":"A Jimenez","year":"2019","unstructured":"Jimenez A, Hull C, Zone J. Dermatitis herpetiformis resistant to dapsone due to dietary iodide ingestion. JAAD Case Rep. 2019;5:713\u20134. https:\/\/doi.org\/10.1016\/j.jdcr.2019.06.011.","journal-title":"JAAD Case Rep."},{"key":"584_CR35","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.jaad.2006.06.012","volume":"58","author":"Y Kawakami","year":"2008","unstructured":"Kawakami Y, Oyama N, Nakamura K, Kaneko F. A case of loclized dermatitis herpetiformis on the face. J Am Acad Dermatol. 2008;58:S59-60. https:\/\/doi.org\/10.1016\/j.jaad.2006.06.012.","journal-title":"J Am Acad Dermatol."},{"key":"584_CR36","first-page":"184","volume":"37","author":"S Karpati","year":"1986","unstructured":"Karpati S, Torok E, Kosnai I. Discrete palmar and plantar symptoms in children with dermatitis herpetiformis Duhring. Cutis. 1986;37:184\u20137.","journal-title":"Cutis"},{"key":"584_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000347108","volume":"227","author":"H Tu","year":"2013","unstructured":"Tu H, Parmentier L, Stieger M, Spanou Z, Horn M, Beltraminelli H, Borradori L. Acral purpura as leading clinical manifestation of dermatitis herpetiformis: report of two adult cases with a review of the literature. Dermatology. 2013;227:1\u20134. https:\/\/doi.org\/10.1159\/000347108.","journal-title":"Dermatology"},{"key":"584_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.det.2011.03.013","volume":"29","author":"V Venning","year":"2011","unstructured":"Venning V. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Dermatol Clin. 2011;29:453\u20138. https:\/\/doi.org\/10.1016\/j.det.2011.03.013.","journal-title":"Dermatol Clin."},{"key":"584_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","volume":"54","author":"KT Amber","year":"2018","unstructured":"Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L. Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis and management. Clin Rev Allergy Immunol. 2018;54:26\u201351. https:\/\/doi.org\/10.1007\/s12016-017-8633-4.","journal-title":"Clin Rev Allergy Immunol."},{"key":"584_CR40","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.jaad.2010.09.777","volume":"64","author":"D Bolotin","year":"2011","unstructured":"Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011;64:1017\u201324. https:\/\/doi.org\/10.1016\/j.jaad.2010.09.777.","journal-title":"J Am Acad Dermatol."},{"key":"584_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1610-0387.2009.07292.x","volume":"8","author":"C Rose","year":"2010","unstructured":"Rose C, Br\u00f6cker E-B, Zillikens Z. Clinical, histological and immunopathological findings in 32 patients with dermatitis herpetiformis Duhring. J Dtsch Dermatol Ges. 2010;8:265\u201370. https:\/\/doi.org\/10.1111\/j.1610-0387.2009.07292.x.","journal-title":"J Dtsch Dermatol Ges."},{"key":"584_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2340\/00015555-2818","volume":"98","author":"E Mansikka","year":"2018","unstructured":"Mansikka E, Salmi T, Kaukinen K, Collin P, Huhtala H, Reunala T, Hervonen K. Diagnostic delay in dermatitis herpetiformis in a high-prevalence area. Acta Derm Venereol. 2018;98:195\u20139. https:\/\/doi.org\/10.2340\/00015555-2818.","journal-title":"Acta Derm Venereol."},{"key":"584_CR43","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3109\/00365521.2014.923502","volume":"49","author":"V Fuchs","year":"2014","unstructured":"Fuchs V, Kurppa K, Huhtala H, Collin P, M\u00e4ki M, Kaukinen K. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol. 2014;49:1304\u201310. https:\/\/doi.org\/10.3109\/00365521.2014.923502.","journal-title":"Scand J Gastroenterol."},{"key":"584_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/01.mcg.0000212618.12455.a8","volume":"41","author":"P Collin","year":"2007","unstructured":"Collin P, Huhtala H, Virta L, Kekkonen L, Reunala T. Diagnosis of celiac disease in clinical practice: physician\u2019s alertness to the condition essential. J Clin Gastroenterol. 2007;41:152\u20136. https:\/\/doi.org\/10.1097\/01.mcg.0000212618.12455.a8.","journal-title":"J Clin Gastroenterol."},{"key":"584_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.amjmed.2005.08.044","volume":"119","author":"D Rampertab","year":"2006","unstructured":"Rampertab D, Pooran N, Brar P, Singh P, Green PH. Trends in the presentation of celiac disease. Am J Med. 2006;119:355\u201365. https:\/\/doi.org\/10.1016\/j.amjmed.2005.08.044.","journal-title":"Am J Med."},{"key":"584_CR46","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/adc.59.6.517","volume":"59","author":"T Reunala","year":"1984","unstructured":"Reunala T, Kosnai I, Karpati S, Kuitunen P, T\u00f6r\u00f6k E, Savilahti E. Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet. Arch Dis Child. 1984;59:517\u201322. https:\/\/doi.org\/10.1136\/adc.59.6.517.","journal-title":"Arch Dis Child."},{"key":"584_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/s0190-9622(86)70137-0","volume":"15","author":"E Ermacora","year":"1986","unstructured":"Ermacora E, Prampolini L, Tribbia G, Pezzoli G, Gelmetti C, Cucchi G, Tettamanti A, Giunta A, Gianotti F. Long-term follow-up of dermatitis herpetiformis in children. J Am Acad Dermatol. 1986;15:24\u201330. https:\/\/doi.org\/10.1016\/s0190-9622(86)70137-0.","journal-title":"J Am Acad Dermatol."},{"key":"584_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2230.1983.tb01815.x","volume":"8","author":"DB Buckley","year":"1983","unstructured":"Buckley DB, English J, Molloy W, Doyle CT, Whelton MJ. Dermatitis herpetiformis: a review of 119 cases. Clin Exp Dermatol. 1983;8:477\u201387. https:\/\/doi.org\/10.1111\/j.1365-2230.1983.tb01815.x.","journal-title":"Clin Exp Dermatol."},{"key":"584_CR49","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1365-2133.1994.tb08557.x","volume":"131","author":"JJ Garioch","year":"1994","unstructured":"Garioch JJ, Lewis HM, Sargent SA, Leonard JN, Fry L. 25 years\u2019 experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol. 1994;131:541\u20135. https:\/\/doi.org\/10.1111\/j.1365-2133.1994.tb08557.x.","journal-title":"Br J Dermatol."},{"key":"584_CR50","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1365-4632.2007.03214.x","volume":"46","author":"J Alonso-Llamazares","year":"2007","unstructured":"Alonso-Llamazares J, Gibson LE, Rogers RS 3rd. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Int J Dermatol. 2007;46:910\u20139. https:\/\/doi.org\/10.1111\/j.1365-4632.2007.03214.x.","journal-title":"Int J Dermatol."},{"key":"584_CR51","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/bjd.13047","volume":"171","author":"K Hervonen","year":"2014","unstructured":"Hervonen K, Salmi TT, Kurppa K, Kaukinen K, Collin P, Reunala T. Dermatitis herpetiformis in children: a long-term follow-up study. Br J Dermatol. 2014;171:1242\u20133. https:\/\/doi.org\/10.1111\/bjd.13047.","journal-title":"Br J Dermatol."},{"key":"584_CR52","first-page":"163","volume":"148","author":"E Antiga","year":"2013","unstructured":"Antiga E, Verdelli A, Calabri A, Fabbri P, Caproni M. Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience. G Ital Dermatol Venereol. 2013;148:163\u20139.","journal-title":"G Ital Dermatol Venereol."},{"key":"584_CR53","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3390\/nu10050602","volume":"10","author":"T Reunala","year":"2018","unstructured":"Reunala T, Salmi TT, Hervonen K, Kaukinen K, Collin P. Dermatitis herpetiformis: a common extraintestinal manifestation of coeliac disease. Nutrients. 2018;10:602. https:\/\/doi.org\/10.3390\/nu10050602.","journal-title":"Nutrients."},{"key":"584_CR54","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1001\/archderm.1996.03890320060010","volume":"132","author":"JJ Zone","year":"1996","unstructured":"Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol. 1996;132:912\u20138. https:\/\/doi.org\/10.1001\/archderm.1996.03890320060010.","journal-title":"Arch Dermatol."},{"key":"584_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1684\/ejd.2019.3533","volume":"29","author":"T Makino","year":"2019","unstructured":"Makino T, Shimizu T. Fibrillar-type dermatitis herpetiformis. Eur J Dermatol. 2019;29:115\u201320. https:\/\/doi.org\/10.1684\/ejd.2019.3533.","journal-title":"Eur J Dermatol."},{"key":"584_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2133.1961.tb14442.x","volume":"73","author":"J Pierard","year":"1961","unstructured":"Pierard J, Whimster I. The histological diagnosis of dermatitis herpetiformis, bullous pemphigoid and erythema multiforme. Br J Dermatol. 1961;73:253\u201366. https:\/\/doi.org\/10.1111\/j.1365-2133.1961.tb14442.x.","journal-title":"Br J Dermatol."},{"key":"584_CR57","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/00000372-198312000-00005","volume":"5","author":"WK Blenkinsopp","year":"1986","unstructured":"Blenkinsopp WK, Haffenden GP, Fry L, Leonard JN. Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid. Am J Dermatopathol. 1986;5:547\u201354. https:\/\/doi.org\/10.1097\/00000372-198312000-00005.","journal-title":"Am J Dermatopathol."},{"key":"584_CR58","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1309\/AJCPXIVSR6OZK1HU","volume":"144","author":"SC Bresler","year":"2015","unstructured":"Bresler SC, Granter SR. Utility of direct immunofluorescence testing for IgA in patients with high and low clinical suspicion for dermatitis herpetiformis. Am J Clin Pathol. 2015;144:880\u20134. https:\/\/doi.org\/10.1309\/AJCPXIVSR6OZK1HU.","journal-title":"Am J Clin Pathol."},{"key":"584_CR59","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1468-3083.2009.03188.x","volume":"23","author":"M Caproni","year":"2009","unstructured":"Caproni M, Antiga E, Melani L, Fabbri P. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009;23:633\u20138. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03188.x.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"584_CR60","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1056\/NEJM198304073081406","volume":"308","author":"J Leonard","year":"1983","unstructured":"Leonard J, Haffenden G, Tucker W, Unsworth J, Swain F, McMinn R, Holborow J, Fry L. Gluten challenge in dermatitis herpetiformis. N Engl J Med. 1983;308:816\u20139. https:\/\/doi.org\/10.1056\/NEJM198304073081406.","journal-title":"N Engl J Med."},{"key":"584_CR61","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3109\/00365521.2014.974204","volume":"50","author":"TT Salmi","year":"2015","unstructured":"Salmi TT, Hervonen K, Kurppa K, Collin P, Kaukinen K, Reunala T. Celiac disease evolving into dermatitis herpetiformis in patients adhering to normal or gluten-free diet. Scand J Gastroenterol. 2015;50:387\u201392. https:\/\/doi.org\/10.3109\/00365521.2014.974204.","journal-title":"Scand J Gastroenterol."},{"key":"584_CR62","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/nu10070800","volume":"10","author":"L Rodrigo","year":"2018","unstructured":"Rodrigo L, Beteta-Gorriti V, Alvarez N, de Castro CG, de Dios A, Palacios L, Santos-Juanes J. Cutaneous and mucosal manifestations associated with celiac disease. Nutrients. 2018;10:800. https:\/\/doi.org\/10.3390\/nu10070800.","journal-title":"Nutrients"},{"key":"584_CR63","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2340\/00015555-3001","volume":"99","author":"V Bonciolini","year":"2019","unstructured":"Bonciolini V, Antiga E, Bianchi B, Del Bianco E, Ninci A, Maio V, Pimpinelli N, Caproni M. Granular IgA deposits in the skin of patients with coeliac disease: is it always dermatitis herpetiformis? Acta Derm Venereol. 2019;99:78\u201383. https:\/\/doi.org\/10.2340\/00015555-3001.","journal-title":"Acta Derm Venereol."},{"key":"584_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2340\/00015555-2471","volume":"97","author":"C Pasternack","year":"2017","unstructured":"Pasternack C, Kaukinen K, Kurppa K, M\u00e4ki M, Collin P, Hervonen K, Reunala T, Huhtala H, Kekkonen L, Salmi T. Gastrointestinal symptoms increase the burden of illness in dermatitis herpetiformis: a prospective study. Acta Derm Venereol. 2017;97:58\u201362. https:\/\/doi.org\/10.2340\/00015555-2471.","journal-title":"Acta Derm Venereol."},{"key":"584_CR65","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MCG.0000000000000533","volume":"51","author":"E Mansikka","year":"2017","unstructured":"Mansikka E, Hervonen K, Salmi TT, Kautiainen H, Kaukinen K, Collin P, Reunala T. The decreasing prevalence of severe villous atrophy in dermatitis herpetiformis: a 45-year experience in 393 patients. J Clin Gastroenterol. 2017;51:235\u20139. https:\/\/doi.org\/10.1097\/MCG.0000000000000533.","journal-title":"J Clin Gastroenterol."},{"key":"584_CR66","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/nu10050641","volume":"10","author":"E Mansikka","year":"2018","unstructured":"Mansikka E, Hervonen K, Kaukinen K, Collin P, Huhtala H, Reunala T. Prognosis of dermatitis herpetiformis patients with and without villous atrophy at diagnosis. Nutrients. 2018;10:641. https:\/\/doi.org\/10.3390\/nu10050641.","journal-title":"Nutrients."},{"key":"584_CR67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1523-1747.1999.00627.x","volume":"113","author":"W Dieterich","year":"1999","unstructured":"Dieterich W, Schuppan D, Laag E, Bruckner-Tuderman L, Reunala T, K\u00e1rp\u00e1ti S, Z\u00e1goni T, Riecken EO, Schuppan D. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol. 1999;113:133\u20136. https:\/\/doi.org\/10.1046\/j.1523-1747.1999.00627.x.","journal-title":"J Invest Dermatol."},{"key":"584_CR68","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1038\/ajg.2010.276","volume":"105","author":"DA Leffler","year":"2010","unstructured":"Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105:2520\u20134. https:\/\/doi.org\/10.1038\/ajg.2010.276.","journal-title":"Am J Gastroenterol."},{"key":"584_CR69","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/MPG.0b013e3181a81384","volume":"50","author":"I Dahlbom","year":"2010","unstructured":"Dahlbom I, Korponay-Szabo IR, Kov\u00e1cs JB, Szalai Z, M\u00e4ki M, Hansson T. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA\/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr. 2010;50:140\u20136. https:\/\/doi.org\/10.1097\/MPG.0b013e3181a81384.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"584_CR70","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2133.2008.08629.x","volume":"159","author":"CM Hull","year":"2008","unstructured":"Hull CM, Liddle M, Hansen N, Meyer LJ, Schmidt L, Taylor T, Jaskowski TD, Hill HR, Zone JJ. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. Br J Dermatol. 2008;159:120\u20134. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08629.x.","journal-title":"Br J Dermatol."},{"key":"584_CR71","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/ajg.2015.296","volume":"110","author":"P Singh","year":"2015","unstructured":"Singh P, Arora S, Lal S, Strand TA, Makharia GK. Risk of celiac disease in the first- and second-degree relatives of patients with celiac disease: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:1539\u201348. https:\/\/doi.org\/10.1038\/ajg.2015.296.","journal-title":"Am J Gastroenterol."},{"key":"584_CR72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/003655202753387356","volume":"37","author":"K Hervonen","year":"2002","unstructured":"Hervonen K, Hakanen M, Kaukinen K, Collin P, Reunala K. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol. 2002;37:51\u20135. https:\/\/doi.org\/10.1080\/003655202753387356.","journal-title":"Scand J Gastroenterol."},{"key":"584_CR73","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/s0190-9622(87)70250-3","volume":"17","author":"LJ Meyer","year":"1987","unstructured":"Meyer LJ, Zone JJ. Familial incidence of dermatitis herpetiformis. J Am Acad Dermatol. 1987;17:643\u20137. https:\/\/doi.org\/10.1016\/s0190-9622(87)70250-3.","journal-title":"J Am Acad Dermatol."},{"key":"584_CR74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2050640614559263","volume":"3","author":"C Ciacci","year":"2015","unstructured":"Ciacci C, Ciclitira P, Hadjivassiliou M, Kaukinen K, Ludvigsson JF, McGough N, Sanders DS, Woodward J, Leonard JN, Swift GL. The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis. United Eur Gastroenterol J. 2015;3:121\u201335. https:\/\/doi.org\/10.1177\/2050640614559263.","journal-title":"United Eur Gastroenterol J."},{"key":"584_CR75","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1056\/NEJM199712253372604","volume":"3378","author":"CM Hardman","year":"1997","unstructured":"Hardman CM, Garioch JJ, Leonard JN, Thomas HJ, Walker MM, Lortan JE, Lister A, Fry L. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med. 1997;3378:1884\u20137. https:\/\/doi.org\/10.1056\/NEJM199712253372604.","journal-title":"N Engl J Med."},{"key":"584_CR76","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/gut.43.4.490","volume":"43","author":"T Reunala","year":"1998","unstructured":"Reunala T, Collin P, Holm K, Pikkarainen P, Miettinen A, Vuolteenaho N, M\u00e4ki M. Tolerance to oats in dermatitis herpetiformis. Gut. 1998;43:490\u20133. https:\/\/doi.org\/10.1136\/gut.43.4.490.","journal-title":"Gut"},{"key":"584_CR77","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/2050640614562599","volume":"3","author":"JF Ludvigsson","year":"2015","unstructured":"Ludvigsson JF, Card T, Ciclitira PJ, Swift GL, Nasr I, Sanders DS, Ciacci C. Support for patients with celiac disease: a literature review. United Eur Gastroenterol J. 2015;3:146\u201359. https:\/\/doi.org\/10.1177\/2050640614562599.","journal-title":"United Eur Gastroenterol J."},{"key":"584_CR78","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jid.2019.03.1150","volume":"139","author":"E Mansikka","year":"2019","unstructured":"Mansikka E, Hervonen K, Kaukinen K, Ilus T, Oksanen P, Lindfors K, Laurila K, Hietikko M, Taavela J, Jernman J, Saavalainen P, Reunala T, Salmi T. Gluten challenge induces skin and small bowel relapse in long-term gluten-free diet-treated dermatitis herpetiformis. J Invest Dermatol. 2019;139:2108\u201314. https:\/\/doi.org\/10.1016\/j.jid.2019.03.1150.","journal-title":"J Invest Dermatol."},{"key":"584_CR79","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/ajg.2010.10","volume":"105","author":"A Rubio-Tapia","year":"2010","unstructured":"Rubio-Tapia A, Rahim MW, See JA, Lahr BD, Wu TT, Murray JA. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol. 2010;105:1412\u201320. https:\/\/doi.org\/10.1038\/ajg.2010.10.","journal-title":"Am J Gastroenterol."},{"key":"584_CR80","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1365-2133.2012.11105.x","volume":"167","author":"K Hervonen","year":"2012","unstructured":"Hervonen K, Alakoski A, Salmi TT, Helakorpi S, Kautiainen H, Kaukinen K, Pukkala E, Collin P, Reunala T. Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol. 2012;167:1331\u20137. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11105.x.","journal-title":"Br J Dermatol."},{"key":"584_CR81","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1067\/mjd.2001.114733","volume":"45","author":"YI Zhu","year":"2001","unstructured":"Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology. Overview and update. J Am Acad Dermatol. 2001;45:420\u201334. https:\/\/doi.org\/10.1067\/mjd.2001.114733.","journal-title":"J Am Acad Dermatol."},{"key":"584_CR82","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2340\/00015555-2184","volume":"96","author":"K Hervonen","year":"2016","unstructured":"Hervonen K, Salmi T, Ilus T, Paasikivi K, Vornanen M, Laurila K, Lindfors K, Viiri K, Saavalainen P, Collin P, Kaukinen K, Reunala T. Dermatitis herpetiformis refractory to gluten free dietary treatment. Acta Derm Venereol. 2016;96:82\u20136. https:\/\/doi.org\/10.2340\/00015555-2184.","journal-title":"Acta Derm Venereol."},{"key":"584_CR83","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/archderm.1984.01650390078016","volume":"120","author":"TP Waldinger","year":"1984","unstructured":"Waldinger TP, Siegle RJ, Weber W, Voorhees JJ. Dapsone-induced peripheral neuropathy. Case report and review. Arch Dermatol. 1984;120:356\u20139.","journal-title":"Arch Dermatol."},{"key":"584_CR84","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/jamadermatol.2016.4676","volume":"153","author":"LN Albers","year":"2017","unstructured":"Albers LN, Zone JJ, Stoff BK, Feldman RJ. Rituximab treatment for recalcitrant dermatitis herpetiformis. JAMA Dermatol. 2017;153:315\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2016.4676.","journal-title":"JAMA Dermatol."},{"key":"584_CR85","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3315\/jdcr.2012.1124","volume":"6","author":"MZ Handler","year":"2012","unstructured":"Handler MZ, Chacon AH, Shiman MI, Schachner LA. Letter to the editor: application of dapsone 5% gel in a patient with dermatitis herpetiformis. J Dermatol Case Rep. 2012;6:132\u20133. https:\/\/doi.org\/10.3315\/jdcr.2012.1124.","journal-title":"J Dermatol Case Rep."},{"key":"584_CR86","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/1203475418795818","volume":"23","author":"AK Cinats","year":"2019","unstructured":"Cinats AK, Parsons LM, Haber RM. Facial involvement in dermatitis herpetiformis: a case report and review of the literature. J Cutan Med Surg. 2019;23:35\u20137. https:\/\/doi.org\/10.1177\/1203475418795818.","journal-title":"J Cutan Med Surg."},{"key":"584_CR87","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2133.1996.tb01496.x","volume":"135","author":"HM Lewis","year":"1996","unstructured":"Lewis HM, Renuala TL, Garioch JJ, Leonard JN, Fry JS, Collin P, Evans D, Fry L. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996;135:363\u20137.","journal-title":"Br J Dermatol."},{"key":"584_CR88","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2036.2011.04972.x","volume":"35","author":"M Tio","year":"2012","unstructured":"Tio M, Cox MR, Eslick GD. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther. 2012;35:540\u201351. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04972.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"584_CR89","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2133.2005.06345.x","volume":"152","author":"K Hervonen","year":"2005","unstructured":"Hervonen K, Vornanen M, Kautiainen H, Collin P, Reunala T. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol. 2005;152:82\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06345.x.","journal-title":"Br J Dermatol."},{"key":"584_CR90","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.1365-2036.2008.03660.x","volume":"27","author":"NR Lewis","year":"2008","unstructured":"Lewis NR, Logan RF, Hubbard RB, West J. No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther. 2008;27:1140\u20137. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03660.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"584_CR91","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2133.2004.05642.x","volume":"150","author":"K Hervonen","year":"2004","unstructured":"Hervonen K, Viljamaa M, Collin P, Knip M, Reunala T. The occurrence of type 1 diabetes in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol. 2004;150:136\u20138. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.05642.x.","journal-title":"Br J Dermatol."},{"key":"584_CR92","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1651-2227.1986.tb10202.x","volume":"75","author":"S K\u00e1rp\u00e1ti","year":"1986","unstructured":"K\u00e1rp\u00e1ti S, K\u00f3snai I, Verkasalo M, Kuitunen P, Simon Z, Koskimies S, Reunala T, Gy\u00f3di E, T\u00f6r\u00f6k E. HLA antigens, jejunal morphology and associated diseases in children with dermatitis herpetiformis. Acta Paediatr Scand. 1986;75:297\u2013301. https:\/\/doi.org\/10.1111\/j.1651-2227.1986.tb10202.x.","journal-title":"Acta Paediatr Scand."},{"key":"584_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.05.091","author":"S Kauppi","year":"2020","unstructured":"Kauppi S, Jokelainen J, Timonen M, Tasanen K, Huilaja L. Atopic dermatitis is associated with dermatitis herpetiformis and celiac disease in children. J Invest Dermatol. 2020. https:\/\/doi.org\/10.1016\/j.jid.2020.05.091.","journal-title":"J Invest Dermatol."},{"key":"584_CR94","doi-asserted-by":"publisher","first-page":"194","DOI":"10.7326\/0003-4819-102-2-194","volume":"102","author":"MJ Cunningham","year":"1985","unstructured":"Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis. Prevalence of clinical thyroid disease and thyroid autoantibodies. Ann Intern Med. 1985;102:194\u20136. https:\/\/doi.org\/10.7326\/0003-4819-102-2-194.","journal-title":"Ann Intern Med."},{"key":"584_CR95","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2133.1997.tb14935.x","volume":"136","author":"T Reunala","year":"1997","unstructured":"Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997;136:315\u20138.","journal-title":"Br J Dermatol."},{"key":"584_CR96","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jid.2018.10.010","volume":"139","author":"O Varpuluoma","year":"2019","unstructured":"Varpuluoma O, Jokelainen J, F\u00f6rsti AK, Timonen M, Huilaja L, Tasanen K. Dermatitis herpetiformis and celiac disease increase the risk of bullous pemphigoid. J Invest Dermatol. 2019;139:600\u20134. https:\/\/doi.org\/10.1016\/j.jid.2018.10.010.","journal-title":"J Invest Dermatol."},{"key":"584_CR97","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40257-015-0149-1","volume":"16","author":"C Pasternack","year":"2015","unstructured":"Pasternack C, Kaukinen K, Kurppa K, M\u00e4ki M, Collin P, Reunala T, Huhtala H, Salmi T. Quality of life and gastrointestinal symptoms in long-term treated dermatitis herpetiformis patients: a cross sectional study in Finland. Am J Clin Dermatol. 2015;16:545\u201352. https:\/\/doi.org\/10.1007\/s40257-015-0149-1.","journal-title":"Am J Clin Dermatol."},{"key":"584_CR98","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.clnu.2016.04.021","volume":"36","author":"JPW Burger","year":"2017","unstructured":"Burger JPW, de Brouwer B, IntHout J, Wahab PJ, Tummers M, Drenth JPH. Systematic review with meta-analysis: dietary adherence influences normalization of health-related quality of life in coeliac disease. Clin Nutr. 2017;36:399\u2013406. https:\/\/doi.org\/10.1016\/j.clnu.2016.04.021.","journal-title":"Clin Nutr."},{"key":"584_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gtc.2018.09.004","volume":"48","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Murray JA. Epidemiology of celiac disease. Gastroenterol Clin North Am. 2019;48:1\u201318. https:\/\/doi.org\/10.1016\/j.gtc.2018.09.004.","journal-title":"Gastroenterol Clin North Am."},{"key":"584_CR100","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1111\/bjd.15995","volume":"178","author":"M Hietikko","year":"2018","unstructured":"Hietikko M, Hervonen K, Salmi T, Ilus T, Zone JJ, Kaukinen K, Reunala T, Lindfors K. Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of patients with dermatitis herpetiformis after a long-term gluten-free diet. Br J Dermatol. 2018;178:e198\u2013201. https:\/\/doi.org\/10.1111\/bjd.15995.","journal-title":"Br J Dermatol."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00584-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-020-00584-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00584-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T01:56:50Z","timestamp":1619315810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-020-00584-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1007\/s40257-020-00584-2","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"11 January 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was funded by the Academy of Finland and Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (grants 9X051 and AA070).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Timo Reunala, Kaisa Hervonen, and Teea Salmi have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"TR wrote the paper, TS and KH commented on the paper, and all authors reviewed the paper.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}